临床肺科杂志
臨床肺科雜誌
림상폐과잡지
JOUNAL OF CLINICAL PULMONARY MEDICINE
2014年
7期
1295-1297
,共3页
细胞角蛋白%神经元特异性烯醇化酶%诊断价值%癌胚抗原%胸腔积液
細胞角蛋白%神經元特異性烯醇化酶%診斷價值%癌胚抗原%胸腔積液
세포각단백%신경원특이성희순화매%진단개치%암배항원%흉강적액
extraembryonic antigen%neuron-specific enolase%cytokinetic%pleural effusion%diagnostic value
目的:通过分别对胸腔积液病人CEA(癌胚抗原),NSE(神经元特异性烯醇化酶)、细胞角蛋白19片段的测定,以及三者联合检测的应用,来判断患者胸腔积液的良恶性的临床价值。方法对NSE、CEA和CYFRA21-1的检测采用电化学发光法。结果 CYFRA21-1灵敏度为63.16%,准确度为75.64%,You den指数为0.51,特异度为87.5%;NSE 的灵敏度为47.37%,准确度为66.67%,You den 指数为0.32,特异度为85%;CEA 灵敏度为60.53%,准确度为79.49%,You den 指数为0.58,特异度为97.5%。对于三者联合使用的结果中, CYFRA21-1和CEA联合检测的阳性率较高。结论肿瘤标志物在对恶性胸腔积液的诊断过程中,联合检测更有临床价值。
目的:通過分彆對胸腔積液病人CEA(癌胚抗原),NSE(神經元特異性烯醇化酶)、細胞角蛋白19片段的測定,以及三者聯閤檢測的應用,來判斷患者胸腔積液的良噁性的臨床價值。方法對NSE、CEA和CYFRA21-1的檢測採用電化學髮光法。結果 CYFRA21-1靈敏度為63.16%,準確度為75.64%,You den指數為0.51,特異度為87.5%;NSE 的靈敏度為47.37%,準確度為66.67%,You den 指數為0.32,特異度為85%;CEA 靈敏度為60.53%,準確度為79.49%,You den 指數為0.58,特異度為97.5%。對于三者聯閤使用的結果中, CYFRA21-1和CEA聯閤檢測的暘性率較高。結論腫瘤標誌物在對噁性胸腔積液的診斷過程中,聯閤檢測更有臨床價值。
목적:통과분별대흉강적액병인CEA(암배항원),NSE(신경원특이성희순화매)、세포각단백19편단적측정,이급삼자연합검측적응용,래판단환자흉강적액적량악성적림상개치。방법대NSE、CEA화CYFRA21-1적검측채용전화학발광법。결과 CYFRA21-1령민도위63.16%,준학도위75.64%,You den지수위0.51,특이도위87.5%;NSE 적령민도위47.37%,준학도위66.67%,You den 지수위0.32,특이도위85%;CEA 령민도위60.53%,준학도위79.49%,You den 지수위0.58,특이도위97.5%。대우삼자연합사용적결과중, CYFRA21-1화CEA연합검측적양성솔교고。결론종류표지물재대악성흉강적액적진단과정중,연합검측경유림상개치。
Objective To evaluate the diagnostic value of combined test of CEA, CYFRA21-1 and NSE in differentiating benign or malignant pleural effusion. Methods The levels of pleural fluid CEA, NSE and CYFRA21-1 were detected by electro-chemiluminescence Immunoassay. Results The sensitivity of CEA was 60. 53%, 97. 5%of specificity, 0. 58 of Youden index,and 79. 49% of accuracy. The sensitivity of NSE was 47. 37%, 85. 00% of specificity, 0. 32 of Youden index, and 66. 67% of accuracy. The sensitivity of CYFRA21-1 was 63. 16%, 87. 5%of specificity, 0. 51 of Youden index, and 75. 64% of accuracy. The combined detection of CEA and CYFRA21-1 had the highest positive detection rate. Conclusion The combined detection of CEA and CYFRA21-1 has better val-ue in the diagnosis of malignant pleural effusion.